REGAL REXNORD CORP·4

Feb 11, 4:42 PM ET

Morton Jerrald R 4

4 · REGAL REXNORD CORP · Filed Feb 11, 2026

Research Summary

AI-generated summary of this filing

Updated

Regal Rexnord (RRX) EVP Jerrald Morton Exercises Options, Sells Shares

What Happened

  • Jerrald R. Morton, Executive Vice President and President, Industrial Powertrain Solutions at Regal Rexnord (RRX), exercised a total of 26,193 derivative awards (code M) on 2026-02-09 and subsequently disposed of the same 26,193 shares (codes F and S) on the same date.
  • The exercises involved six tranches (3,376; 3,408; 3,776; 6,170; 4,725; 4,738) with exercise/settlement amounts totaling $2,676,429. Shares sold included 18,215 shares surrendered for tax/exercise payment (F) for $3,945,187 and 7,978 shares sold in open-market transactions (S) for $1,721,445, for combined proceeds of $5,666,632.
  • This was effectively a cashless exercise/settlement: Morton exercised vested derivatives and sold all resulting shares, so there was no net increase in beneficial ownership.

Key Details

  • Transaction date: 2026-02-09 (all activity same day).
  • Derivatives exercised: 26,193 shares across multiple strike levels; total exercise/settlement reported $2,676,429.
  • Shares sold: 26,193 shares disposed — 18,215 withheld/surrendered for tax (F) and 7,978 sold in the open market (S); total proceeds ≈ $5,666,632.
  • Reported sale prices were around $215–$216 per share (Form footnote notes a weighted-price range; the filer can provide breakdown on request).
  • Net effect: no net change in beneficial ownership (all exercised shares were disposed).
  • Notable footnotes: F1 explains the reported sale price is a weighted average (range available on request). F2/F3 describe vesting schedules for the underlying Stock Appreciation Rights exercised.
  • Filing timeliness: No late-filing indication provided.

Context

  • These were derivative exercises (stock appreciation rights/options) that were immediately settled and sold — a common, routine way for insiders to satisfy tax withholding or realize value from vested awards. Codes: M = exercise/conversion of derivative, F = payment of exercise price/tax liability (often via share surrender), S = open-market sale.
  • Because the insider sold all shares received on exercise, the transactions do not signal an increase in the insider’s stake in RRX.

Insider Transaction Report

Form 4
Period: 2026-02-09
Morton Jerrald R
EVP and Pres. IPS*
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-09$76.99/sh+3,376$259,91827,405.762 total
  • Exercise/Conversion

    Common Stock

    2026-02-09$74.04/sh+3,408$252,32830,813.762 total
  • Exercise/Conversion

    Common Stock

    2026-02-09$78.05/sh+3,776$294,71734,589.762 total
  • Exercise/Conversion

    Common Stock

    2026-02-09$84.39/sh+6,170$520,68640,759.762 total
  • Exercise/Conversion

    Common Stock

    2026-02-09$133.77/sh+4,725$632,06345,484.762 total
  • Exercise/Conversion

    Common Stock

    2026-02-09$151.27/sh+4,738$716,71750,222.762 total
  • Tax Payment

    Common Stock

    2026-02-09$216.59/sh18,215$3,945,18732,007.762 total
  • Sale

    Common Stock

    [F1]
    2026-02-09$215.77/sh7,924$1,709,76124,083.762 total
  • Sale

    Common Stock

    2026-02-09$216.37/sh54$11,68424,029.762 total
  • Exercise/Conversion

    Stock Appreciation Rights

    [F2]
    2026-02-093,3760 total
    Exercise: $76.99From: 2019-05-10Exp: 2027-05-10Common Stock (3,376 underlying)
  • Exercise/Conversion

    Stock Appreciation Rights

    [F2]
    2026-02-093,4080 total
    Exercise: $74.04From: 2020-05-09Exp: 2028-05-09Common Stock (3,408 underlying)
  • Exercise/Conversion

    Stock Appreciation Rights

    [F2]
    2026-02-093,7760 total
    Exercise: $78.05From: 2021-05-08Exp: 2029-05-08Common Stock (3,776 underlying)
  • Exercise/Conversion

    Stock Appreciation Rights

    [F3]
    2026-02-096,1700 total
    Exercise: $84.39From: 2021-02-18Exp: 2030-02-18Common Stock (6,170 underlying)
  • Exercise/Conversion

    Stock Appreciation Rights

    [F3]
    2026-02-094,7250 total
    Exercise: $133.77From: 2022-02-23Exp: 2031-02-23Common Stock (4,725 underlying)
  • Exercise/Conversion

    Stock Appreciation Rights

    [F3]
    2026-02-094,7380 total
    Exercise: $151.27From: 2023-02-23Exp: 2032-02-23Common Stock (4,738 underlying)
Holdings
  • Stock Appreciation Rights

    [F3]
    Exercise: $154.20From: 2024-02-23Exp: 2033-02-23Common Stock (5,304 underlying)
    5,304
  • Stock Appreciation Rights

    [F3]
    Exercise: $168.47From: 2025-02-23Exp: 2034-02-23Common Stock (5,171 underlying)
    5,171
Footnotes (3)
  • [F1]The price in Column 4 is a weighted average price. The prices actually received ranged from $215.34 to $216.23. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price.
  • [F2]The Stock Appreciation Rights vest and become exercisable 40% on the second anniversary, 60% on the third anniversary, 80% on the fourth anniversary and 100% on the fifth anniversary of the date of the grant.
  • [F3]The Stock Appreciation Rights vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant.
Signature
/s/ Molly Johnson, as Power of Attorney|2026-02-11

Documents

1 file
  • 4
    wk-form4_1770846119.xmlPrimary

    FORM 4